Table 3 Cervical test positivity rates for various clinical groups
Cytological/histological diagnosis | TERC positive cases [% (positive/total)] | C-MYC positive cases [% (positive/total)] |
|---|---|---|
NILM-negative | 7.3 (8/109) | 19.3 (21/109) |
NILM-CIN1 | 0.0 (0/15) | 33.3 (5/15) |
NILM-CIN2+ | 37.5 (3/8) | 37.5 (3/8) |
ASCUS-negative | 12.8 (5/39) | 23.1 (9/39) |
ASCUS-CIN1 | 14.3 (1/7) | 14.3 (1/7) |
ASCUS-CIN2+ | 100.0 (4/4) | 75.0 (3/4) |
LSIL-negative | 18.2 (2/11) | 36.4 (4/11) |
LSIL-CIN1 | 75.0 (3/4) | 50.0 (2/4) |
LSIL-CIN2+ | 100.0 (6/6) | 100.0 (6/6) |
ASC-H-negative | 0.0 (0/3) | 0.0 (0/3) |
ASC-H -CIN1 | 0.0 (0/2) | 0.0 (0/2) |
ASC-H -CIN2+ | 100.0 (9/9) | 66.7 (6/9) |
HSIL-negative | 0.0 (0/2) | 0.0 (0/2) |
HSIL-CIN1 | 100.0 (1/1) | 100.0 (1/1) |
HSIL-CIN2+ | 100.0 (20/20) | 95.0 (19/20) |
SCC-CIN2+ | 100.0 (3/3) | 100.0 (3/3) |